| Patents for C07J 61 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms (90) |
|---|
| 09/18/2014 | WO2014144945A2 Power assisted bow |
| 09/18/2014 | US20140275572 Synthesis of ent-progesterone and intermediates thereof |
| 11/06/2013 | EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 10/23/2013 | EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 09/26/2013 | US20130252930 Cyp11b, cyp17, and/or cyp21 inhibitors |
| 09/04/2013 | CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors |
| 07/24/2013 | CN103214542A B-nor-6-(4'-alkyl) aminothizone cholestane compound, and preparation method and application thereof in anticancer drugs |
| 07/17/2013 | CN103204892A Beta-norcholest-6-(4'-phenyl)-aminothizone compound and synthesis method and application thereof in preparing antitumor drug |
| 07/04/2013 | WO2013101719A2 Amooranin compounds and analogs thereof and related methods of use |
| 01/30/2013 | CN102286055B B-drop-3, 6-disubstituted cholestane compound and preparation method and application thereof to preparation of antitumor drug |
| 11/08/2012 | WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 09/26/2012 | CN102218069B Applicationof A-nor-5 alpha-androstane compounds in preparation of malignant tumor resistant medicaments |
| 06/21/2012 | WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors |
| 06/21/2012 | CA2819515A1 Cyp11b, cyp17, and/or cyp21 inhibitors |
| 05/09/2012 | CN101508717B Synthesis of tuberculosis resistant compound of arguesterol |
| 12/21/2011 | CN102286055A B-降-3,6-二取代胆甾烷化合物及其制备方法和在制备抗肿瘤药物中的应用 B- drop cholestane-3,6-di-substituted compound and its preparation method and application in the preparation of anticancer drugs |
| 10/19/2011 | CN102218069A Applicationof A-nor-5 alpha-androstane compounds in preparation of malignant tumor resistant medicaments |
| 10/13/2011 | WO2011088160A3 Novel cyp17 inhibitors |
| 12/22/2010 | CN101250211B Pregna-16-ene-20S-acetate compound and method for synthesizing same |
| 08/19/2009 | CN101508717A Synthesis of tuberculosis resistant compound of arguesterol |
| 12/17/2008 | CN100443496C A-decarbon-5 alpha-androstane-2-one-17 beta-alcohol ester and its prepn and use |
| 10/29/2008 | CN100429219C Celosia argentea suponin compound and its pharmaceutical use |
| 08/27/2008 | CN101250211A Pregna-16-ene-20S-acetate compound and method for synthesizing same |
| 03/06/2007 | US7186756 Steroid derivatives and use thereof as medicaments |
| 12/13/2006 | CN1878787A Detection of cholesterol ozonation products |
| 11/16/2006 | US20060258753 Such as 2-oxo-3-hydroxy-25-ethylidene-A-nor cholest-3-ene; for increasing synthesis of collagen |
| 10/25/2006 | CN1850836A Celosia argentea suponin compound and its pharmaceutical use |
| 10/18/2006 | CN1847258A A-decarbon-5 alpha-androstane-2-one-17 beta-alcohol ester and its prepn and use |
| 09/28/2006 | US20060217359 Therapeutic procedures |
| 09/21/2006 | US20060210554 Detection of cholesterol ozonation products |
| 06/21/2006 | EP1670812A2 Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases |
| 06/14/2006 | EP1668026A1 Detection of cholesterol ozonation products |
| 04/26/2006 | EP1648915A1 Steroid derivatives and use thereof as medicaments |
| 08/18/2005 | WO2005023830A3 Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases |
| 04/21/2005 | US20050085557 Oxidation of cholesterol in atherosclerosis plaque; cytotoxic |
| 04/21/2005 | US20050085556 Generated by atherosclerosis plaque; contacting with antibody; measurement; calibration |
| 03/17/2005 | WO2005023831A1 Detection of cholesterol ozonation products |
| 03/17/2005 | WO2005023830A2 Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases |
| 03/17/2005 | CA2537984A1 Detection of cholesterol ozonation products |
| 03/17/2005 | CA2537976A1 Ozonation products of cholesterol for the treatment and prevention of artherosclerosis and/or cardiovascular diseases |
| 02/17/2005 | WO2005014614A1 Steroid derivatives and use thereof as medicaments |
| 02/17/2005 | CA2536486A1 Steroid derivatives and use thereof as medicaments |
| 10/27/2004 | CN1172950C Compound with breeding-resisting action and its prepn |
| 07/16/2003 | CN1114610C Compound with effect on treating prostatoplasia and preparing method |
| 12/11/2002 | CN1384109A Compound with breeding-resisting action and its prepn |
| 08/27/2002 | CA2033392C A-nor-steroid-3-carboxylic acid derivatives |
| 01/16/2002 | CN1331082A Compound with effect on treating prostatoplasia and its preparing process |
| 12/09/1998 | CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors |
| 10/22/1997 | CN1036200C Preparation of A-norsteroid-3-carboxylic |
| 01/15/1997 | CN1033809C Novel a-nor-steroid-3-carboxylic acid derivs. preparation method |
| 07/24/1996 | CN1127258A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127257A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127256A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 09/06/1995 | EP0669931A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 11/15/1994 | US5364277 Three-dimensional electroformed circuitry |
| 10/19/1994 | CN1026236C Steroid 5-alpha-reductase inhibitors |
| 05/26/1994 | WO1994011385A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 03/01/1994 | CA1327352C Steroid 5-.alpha.-reductase inhibitors |
| 12/22/1993 | CN1079747A Steroid 5-alpha-reductase inhibitors |
| 03/31/1992 | US5100917 Novel a-nor-steroid-3-carboxylic acid derivatives |
| 08/20/1991 | US5041433 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase |
| 07/10/1991 | CN1052866A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/03/1991 | EP0435321A2 Novel A-nor-steroid-3-carboxylic acid derivatives |
| 06/25/1991 | US5026882 Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase |
| 05/21/1991 | US5017568 Enzyme inhibitors, carboxylation |
| 05/15/1991 | EP0427434A2 11-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha-reductase |
| 05/02/1991 | CA2028622A1 11-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5--reductase |
| 03/19/1991 | US5001120 Use of A-Nor-steroids as malignant cells growth inhibitors |
| 02/21/1991 | WO1991001991A1 New topically active steroidal anti-inflammatory agents |
| 01/31/1991 | CA2000369A1 Topically active steroidal anti-inflammatory agents |
| 08/07/1990 | US4946834 Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors |
| 06/27/1990 | EP0375351A1 Phosphonic acid substituted steroids as steroid 5alpha-reductase inhibitors |
| 06/27/1990 | EP0375349A1 Phosphinic acid substituted steroids as inhibitors of steroid 5alpha-reductase |
| 06/23/1990 | CA2005214A1 Phosphinic acid substituted steroids as inhibitors of steroid 5-reductase |
| 06/23/1990 | CA2005165A1 Phosphonic acid substituted steroids as steroid 5.alpha.-reductase inhibitors |
| 03/20/1990 | US4910226 Estrane compound |
| 03/20/1990 | US4910192 Topically active steroidal anti-inflammatory agents |
| 02/01/1989 | CN1030765A Steroid 5-alpha-reductase inhibitors |
| 11/02/1988 | EP0289327A2 Steroid 5-alpha-reductase inhibitors |
| 06/24/1986 | CA1206471A1 Preparation process of novel derivatives of 3-keto delta 4,9 19-nor steroids |
| 09/10/1985 | US4540686 3-Keto-19-nor-Δ4,9 -steroids |
| 06/11/1985 | US4522831 Method of totally suppressing ovarian follicular development |
| 10/16/1984 | US4477445 3-Keto-19-nor-Δ4,9-steroids |
| 09/15/1983 | WO1983003099A1 3-keto-delta 4,9-19-norsteroids |
| 01/05/1982 | US4309565 Process for synthesizing A-nor and A-nor-18-homo-steroids |
| 05/19/1981 | CA1101409A1 Steroids |
| 08/26/1980 | US4219489 Synthesis of steroids |
| 12/19/1978 | US4130665 Skin disorders |
| 12/20/1977 | US4064185 Olefinically unsaturated substituents at C-11 of steroid cyclization precursors |
| 06/28/1977 | US4032579 11-substituted steroids and intermediates |